Evaluation of SARS-CoV-2 patients with annual RT-PCR analysis results
Selen Zeliha Mart Komurcu 1, Yakup Artik 2 3 * , Nevra Pelin Cesur 4 5, Cemal Kazezoglu 1, Yasemin Tuba Sutasir 1
More Detail
1 Republic of Turkey Ministry of Health, Ministry of Health University of Health Science, Kanuni Sultan Suleyman Research and Training Hospital, Istanbul, Turkey
2 Republic of Turkey Ministry of Health, Health Institutes of Turkey, COVID‐19 Diagnostic Center, Istanbul Provincial Directorate of Health, Kartal Dr. Lutfi Kirdar City Hospital, Istanbul, Turkey
3 Istanbul Genetic Group, Genetic Diagnosis Center, İstanbul, Turkey
4 Republic of Turkey Ministry of Health, Health Institutes of Turkey, COVID‐19 Diagnostic Center, Istanbul Provincial Directorate of Health, Prof. Dr. Murat Dilmener Emergency Hospital, Istanbul, Turkey
5 Yıldız Technical University, Molecular Biology and Genetics Department, Istanbul, Turkey
* Corresponding Author

Abstract

Background: Nowadays, people have faced with a pandemic called COVID-19. The reliable detection of the virus is important to prevent transmission of the virus. RT-PCR is a gold standard method for the diagnosis of the disease used at all over the world. The highest number of sample size (1,461,258 patient sample) and differing results are reported with our study regarding the PCR positivity rates.
Method/Study Design: The study was aimed to evaluate the positivity and negativity of the patients with RT-PCR from all the samples studied between March 25, 2020 and March 25, 2021, when the pandemic was declared and started to be seen in Turkey, and to investigate its contribution to the total test capacity of our country.
Results/Conclusions: 1,461,258 patient is observed, and this frequency male is 58% and female is 42% of the population. The maximum number of admissions is noticed during the Autumn-2020 involved age ranged from 25 to 35. 14.6% positive result is got while the 85.4% negative result is observed. When the age distribution of COVID-19 (+) patients is evaluated, COVID-19 (+) rate is highest in the 6-15 age range, followed by the 66-75 age range and the highest COVID-19 (+) rate are November and October, respectively. Additionally, the highest COVID-19 (+) rate is in Autumn. According to the test results, it was determined that 7.5% of the male participants were COVID-19 (+) and 7.1% of the female participants were COVID-19 (+).

License

This is an open access article distributed under the Creative Commons Attribution License (CC BY 4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Article Type: Research Article

https://doi.org/10.29333/jcei/12376

J CLIN EXP INVEST, 2022 - Volume 13 Issue 4, Article No: em00804

Publication date: 18 Aug 2022

Article Views: 196

Article Downloads: 64

Open Access References How to cite this article